new_0222_0726|QNRX|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0726|QNRX|1|Quoin Pharmaceuticals Ltd Total Current Assets (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Cash and Short Term Investments (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Inventories (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Net PP&E (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Goodwill and Intangibles (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Total Liabilities (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Total Current Liabilities (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Total Long Term Liabilities (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Total Deposits (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Book Value (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Retained Earnings (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Treasury Stock (Quarterly) (USD)|Quoin Pharmaceuticals Ltd EV to Revenues|Quoin Pharmaceuticals Ltd EV to Earnings|Quoin Pharmaceuticals Ltd EV to Free Cash Flow|Quoin Pharmaceuticals Ltd EV to Assets (Quarterly)|Quoin Pharmaceuticals Ltd PS Ratio|Quoin Pharmaceuticals Ltd PE Ratio|Quoin Pharmaceuticals Ltd Price to Book Value|Quoin Pharmaceuticals Ltd PEG Ratio|Quoin Pharmaceuticals Ltd Debt to Equity Ratio|Quoin Pharmaceuticals Ltd Dividend Yield|Quoin Pharmaceuticals Ltd Shareholder Yield (TTM)|Quoin Pharmaceuticals Ltd Percent of Shares Outstanding Short|Quoin Pharmaceuticals Ltd Total Receivables (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Total Payables (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Total Capital Stock (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Return on Invested Capital|Quoin Pharmaceuticals Ltd Quality Ratio Score|Quoin Pharmaceuticals Ltd Momentum Score|Quoin Pharmaceuticals Ltd Beta (1Y)|Quoin Pharmaceuticals Ltd Sustainable Growth Rate (TTM)|Quoin Pharmaceuticals Ltd Institutional Investor Ownership Percentage|Quoin Pharmaceuticals Ltd Average Diluted Shares Outstanding (Quarterly)|Quoin Pharmaceuticals Ltd Total Employees (Annual)|Quoin Pharmaceuticals Ltd EPS Diluted (Quarterly) (USD)|Quoin Pharmaceuticals Ltd SG&A Expense (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Shares Outstanding|Quoin Pharmaceuticals Ltd Repurchase of Capital Stock (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Ordinary Shares Number (Quarterly)|Quoin Pharmaceuticals Ltd Payout Ratio|Quoin Pharmaceuticals Ltd Quick Ratio (Quarterly)|Quoin Pharmaceuticals Ltd Normalized Diluted EPS (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Stock Buybacks (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Effective Tax Rate (TTM)|Quoin Pharmaceuticals Ltd Return on Equity|Quoin Pharmaceuticals Ltd Net Income (TTM) (USD)|Quoin Pharmaceuticals Ltd Revenue (TTM) (USD)|Quoin Pharmaceuticals Ltd Dividend Per Share (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Revenue (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Gross Profit (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Pre-Tax Income (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Net Income (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Net Interest Income (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Price (USD)|Quoin Pharmaceuticals Ltd Total Return Price (USD)|Quoin Pharmaceuticals Ltd Enterprise Value (USD)|Quoin Pharmaceuticals Ltd 30-Day Average Daily Volume|Quoin Pharmaceuticals Ltd 1 Year Price Returns (Daily)|Quoin Pharmaceuticals Ltd Short Interest|Quoin Pharmaceuticals Ltd PE Ratio (Forward)|Quoin Pharmaceuticals Ltd PE Ratio (Forward 1y)|Quoin Pharmaceuticals Ltd PS Ratio (Forward)|Quoin Pharmaceuticals Ltd PS Ratio (Forward 1y)|Quoin Pharmaceuticals Ltd Quarterly EPS Estimates (USD)|Quoin Pharmaceuticals Ltd Quarterly Revenue Estimates (USD)|Quoin Pharmaceuticals Ltd Quarterly EPS Surprise|Quoin Pharmaceuticals Ltd Quarterly Revenue Surprise|Quoin Pharmaceuticals Ltd Quarterly Actual EPS (USD)|Quoin Pharmaceuticals Ltd Quarterly Actual Revenue (USD)|Quoin Pharmaceuticals Ltd Revenue Estimates for Current Fiscal Year (USD)|Quoin Pharmaceuticals Ltd Revenue Estimates for Next Fiscal Year (USD)|Quoin Pharmaceuticals Ltd Price Target (USD)|Quoin Pharmaceuticals Ltd Consensus Recommendation|Quoin Pharmaceuticals Ltd Price Target Num Estimates|Quoin Pharmaceuticals Ltd EPS Estimates for Current Fiscal Year (USD)|Quoin Pharmaceuticals Ltd EPS Estimates for Next Fiscal Year (USD)|Quoin Pharmaceuticals Ltd Research and Development Expense (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Reconciled Depreciation (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Non-Operating Interest Expense (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Land and Improvements (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Buildings and Improvements (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Other Properties (Quarterly) (USD)|Quoin Pharmaceuticals Ltd Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0726|QNRX|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0726|QNRX|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|monthly|monthly|monthly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0726|QNRX|5|92|92|||92|92|92|92||92|92||||1.45454545455|||||||1.45||15.4||92|92|||31.6470588235|30.462962963||30.6666666667|152.333333333||152.333333333|152.333333333|||92|||152.333333333|||||||||152.333333333|152.333333333|152.333333333|6.97594501718|6.97594501718|1.45454545455|7|7.01687763713|15.4||||1.44117647059||91.4|||||14.25|23|19|19|19|||152.333333333|182.5|152.333333333||||||
new_0222_0726|QNRX|6|1|1|||1|1|1|1||1|1||||77|||||||1400||5||1|1|||51|54||3|3||3|3|||1|||3|||||||||3|3|3|291|291|77|284|237|5||||34||5|||||4|1|3|3|3|||3|2|3||||||
new_0222_0726|QNRX|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0726|QNRX|201606|||||||||||||||||||||||||||||||||||||||||||||||||||||||99.9|99.9|||||||||||||||||||||||||||||96.4|
new_0222_0726|QNRX|201609|||||||||||||||||||||||||||||||||||||||||||||||||||||||92|92||12857.7|||||||||||||||||||||||||||86|67.62
new_0222_0726|QNRX|201612|||||||||||||||||||||||||||||||||||||||||||||||||||||||61.8|61.8||3832.0333|||||||||||||||||||||||||||63.6|122.8
new_0222_0726|QNRX|201703|||||||||||||||||||||||||||||||||||||||||||||||||||||||218|218||462564|||||||||||||||||||||||||||162|184.6
new_0222_0726|QNRX|201706||||||||||||||||||||||||||||||9|8.4763||||||||||||||||||||||||162|162||28783.0333|48.5485||||||||||||||||||||||||||151|159.4
new_0222_0726|QNRX|201709||||||||||||||||||||||||||||||9|7.0759||||||||||||||||||||||||162.2|162.2||47969.7|89.6396||||||||||||||||||||||||||176.4|166
new_0222_0726|QNRX|201712||||||||||||||||||||||||||||||10|13.7281||||||||||||||||||||||||136.8|136.8||32338.7667|164.7998||||||||||||||||||||||||||168|144.2
new_0222_0726|QNRX|201803||||||||||||||||||||||||||||||2|2.6913||||||||||||||||||||||||124|124||26597.5333|-42.0183||||||||||||||||||||||||||136.2|145.6
new_0222_0726|QNRX|201806||||||||||||||||||||||||||||||2|2.7957||||||||||||||||||||||||143|143||12237|-15.9437||||||||||||||||||||||||||133.98|109
new_0222_0726|QNRX|201809||||||||||||||||||||||||||||||2|2.4184||||||||||||||||||||||||96|96||12729.7|-41.0766||||||||||||||||||||||||||94.8|66.8
new_0222_0726|QNRX|201812||||||||||||||||||||||||||||||2|2.0677||||||||||||||||||||||||47.2|47.2||18619.1667|-64.9369||||||||||||||||||||||||||54|22.8
new_0222_0726|QNRX|201903||||||||||||||||||||||||||||||1|1.3775||||||||||||||||||||||||20.216|20.216||513569.4|-84.318||||||||||||||||||||||||||17.302|13.5
new_0222_0726|QNRX|201906||||||||||||||||||||||||||||||1|0.7475||||||||||||||||||||||||10.4|10.4||79384.7333|-93.2706||||||||||||||||||||||||||13.78|10.01
new_0222_0726|QNRX|201909||||||||||||||||||||||||||||||1|0.8776||||||||||||||||||||||||9.7|9.7||146012.3333|-90.1771||||||||||||||||||||||||||9.88|9.52
new_0222_0726|QNRX|201912||||||||||||||||||||||||||||||1|0.6583||||||||||||||||||||||||8.8788|8.8788||24190.7333|-81.768||||||||||||||||||||||||||9.48|9.11
new_0222_0726|QNRX|202003||||||||||||||||||||||||||||||2|0.8064||||||||||||||||||||||||5.88|5.88||529334.5|-69.1504||||||||||||||||||||||||||9.84|11.96
new_0222_0726|QNRX|202006||||||||||||||||||||||||||||||5|3.1952|||8.3461||-0.042|0.3242||||||-0.042|||||||||-0.3502|-0.3502||12.6|12.6||183161.6333|26.5385|||||||||||||||||||0.026|||||||12.88|10.64
new_0222_0726|QNRX|202009||||||||||||||||||||||||||||||5|2.2108|||8.3461||-0.0393|0.3021||||||-0.0393|||||||||-0.3281|-0.3281||8.6|8.6||167325.6667|2.6804|||||||||||||||||||0.026|0.026||||||7.16|7.64
new_0222_0726|QNRX|202012||||||||||||||||||||||||||||||3|2.162||||||||||||||||||||||||9.32|9.32||244878.0667|2.6667||||||||||||||||||||||||||12.12|14.62
new_0222_0726|QNRX|202103||||||||||||||||||||||||||||||7|1.8651||||||||||||||||||||||||12.24|12.24||3878917.7333|108.1633||||||||||||||||||||||||||10|10.88
new_0222_0726|QNRX|202106|2.0223|1.7206|||0.8606|17.7816|13.1119|4.6697||-14.8487|-14.8488|||||||||||||||5.4428|0.0001|||3|-1.0044|||8.3461||-0.5197|0.7376|||3338.4308|||-0.4298|||||||||-4.3375|-4.3375|-0.3875|14.68|14.68||3152208.9667|11.5502|||||||||||||||||||0.2393||0.3875|||||15.68|21.2
new_0222_0726|QNRX|202109|0.9587|0.6528|||0.8346|18.0962|13.5733|4.5228||-16.2528|-16.2529||||-18.6305|||||||||0.1807||5.5598|0.0001|||9|0.4519||0.103|8.3461||-0.1682|1.0428|8.3461||3338.4308|||-0.1682||||-6.42|||||-1.4041|-1.4041|-0.2482|18.49|18.49|102.7091|3645203.5333|90.3614|15080||||||||||||||||||0.26|0.026|0.2482|||||13.2|3.79
new_0222_0726|QNRX|202112|||||||||||||||-3.7639|||||||||2.3136||||||2|-1.7742||0.1216||||||||||||||||||||||1.91|1.91|20.7504|1960306.5|-77.9221|193093||||18.9874||||||||0.4|8|2|1||||||||||1.22|1.35
new_0222_0726|QNRX|202203||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
new_0222_0726|QNRX|202206||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
new_0222_0726|QNRX|202209||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
new_0222_0726|QNRX|202212||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||